Vital Biopharmaceutical Insights and Analytics

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Featured Report
Colorectal Cancer (Stage IV): Blockbuster Opportunity Awaits a Therapy That Would Improve Overall Survival over IFL/Bevacizumab

A therapy that would improve median overall survival over IFL (bolus 5-fluorouracil, generics/leucovorin, generics/irinotecan*) plus bevacizumab (Roche/Genentech/Chugai’s Avastin), would earn a 60 percent patient share ...Learn More

Featured Webinar
What Key Drug Attributes Will Emerging Therapies Need to Erode the Dominance of TNF-alpha Inhibitors in Moderate to Severe Psoriasis?

March 31, 2010...Learn More

View Webinar schedule and archive

Search Reports

Filter results:

TOP TEN REPORTS

See which reports have been searched on the most.

In the Spotlight

Thursday, April 8, 2010
Basking Ridge, NJ
9 a.m. to 3 p.m. ET

Join us for our complimentary DecisionBase 2010 one-day seminar. To reserve your place, please register by March 24, 2010. Click here to view the agenda and learn more.

Latest Press Releases [ view all ]

March 17, 2010

A Therapy’s Effect on Overall Clinical Success is the Attribute That Most Influences Surveyed Infectious Disease Specialists’ Prescribing Decisions in treating Complicated Skin and Skin Structure Infections ...Read More
March 15, 2010

A Stage IV Colorectal Cancer Therapy That Improves Median Overall Survival Over IFL/Bevacizumab Would Earn a 60 Percent Patient Share in the United States, According to Surveyed Oncologists ...Read More
March 15, 2010

The Irritable Bowel Syndrome Drug Market Will More Than Triple From $459 Million in 2008 to $1.52 Billion in 2018 ...Read More

Recent Reports [ view all ]

Multiple Myeloma (Event Driven)

In 2009, multiple myeloma was the second most commonly diagnosed hematologic malignancy in the United States after... Read More
Venous Thromboembolism (Treatment and Secondary Prophylaxis): Emerging Oral Anticoagulants Are Set to Challenge the Treatment Paradigm

Despite the availability of efficacious drugs to treat the condition, there remains a high level of unmet need in the... Read More
Gastric Cancer (Event Driven)

Last Updated 17 March 2010
Gastric cancer (GC) is the fourth-most common malignancy in terms of incidence and... Read More